| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.007 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.0079 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.004 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |